Displaying 321 to 340 of 428 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Sirocco Systems Inc High-speed data networking equipment company. |
United States | 31 Dec 1998 | Seed Active |
|
|
|
Sirtris Pharmaceuticals Inc |
United States | 19 Apr 2006 | Series C Active |
|
|
SiteAdvisor Inc Service that reports on the safety of web sites by crawling the web and testing the sites it finds for malware and spam. |
United States | 1 Apr 2005 | N/A Initial investment. Round participant. Exited (Trade sale) |
|
|
Skybox Imaging Inc |
United States | 1 Jul 2010 | Series B Active |
|
|
|
Skybox Imaging Inc |
United States | 1 Apr 2012 | Series C |
|
|
Skype Technologies SA Developer and operator of the VoIP software and service Skype. |
Luxembourg | 1 Aug 2003 | Series A Active |
|
|
Smilebox Inc |
United States | 1 Dec 2007 | Series B Active |
|
|
Smule Inc Sonic technologies for distributed devices. |
United States | 1 Jan 2008 | Seed Active |
|
|
Snapdeal.com Indian online group coupon website |
India | 1 Jul 2011 | Series B Active |
|
|
|
Snapdeal.com Indian online group coupon website |
India | 1 Apr 2013 | Venture Active |
|
|
|
Soap.com |
United States | 31 Dec 2007 | N/A Active |
|
|
|
Soleil Securities Group Inc An institutional research, sales and trading firm that provides a wide array of services to the asset management community. |
United States | 30 Oct 2003 | N/A Active |
|
|
|
Soluto Ltd |
Israel | 1 Nov 2009 | Series A Active |
|
|
|
Sonus Networks Inc |
United States | 31 Dec 1997 | N/A Active |
|
|
|
Spanco Power Distribution Ltd |
India | 1 May 2011 | N/A Active |
|
|
Staples Inc One of the world's largest office products companies. |
United States | N/A Active |
||
|
|
Storwize Inc |
United States | 1 Apr 2008 | Series C Active |
|
|
|
Stream Machine Co Inc |
United States | 31 Dec 1998 | N/A Active |
|
|
|
StreamBase Systems Inc Complex event processing technology. |
United States | 1 Jan 2005 | Series B Active |
|
|
|
Stromedix Inc A biotechnology company committed to developing novel drugs to treat fibrotic organ failure. |
United States | 21 Apr 2008 | Series B Active |